Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Antiviral activities of sulfated polysaccharides isolated from Sphaerococcus coronopifolius (Rhodophytha, Gigartinales) and Boergeseniella thuyoides (Rhodophyta, Ceramiales).

Bouhlal R, Haslin C, Chermann JC, Colliec-Jouault S, Sinquin C, Simon G, Cerantola S, Riadi H, Bourgougnon N.

Mar Drugs. 2011;9(7):1187-209. doi: 10.3390/md9071187. Epub 2011 Jul 6.

2.

A recombinant human monoclonal anti-R7V antibody as a potential therapy for HIV infected patients in failure of HAART.

Haslin C, Lévêque M, Ozil A, Cérutti P, Chardès T, Chermann JC, Duonor-Cérutti M.

Hum Antibodies. 2007;16(3-4):73-85.

PMID:
18334743
3.

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983.

Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L.

Rev Invest Clin. 2004 Mar-Apr;56(2):126-9. No abstract available.

PMID:
15378805
4.

[Preliminary investigation on the relation between clinical progress and anti-small monomolecular peptides antibody in individual infected with HIV].

Xu X, Xing H, Gong W, Chen H, Si C, Wang Y, Chermann JC.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002 Sep;16(3):286-7. Chinese.

PMID:
12665943
5.

Anti-R7V antibodies as therapeutics for HIV-infected patients in failure of HAART.

Haslin C, Chermann JC.

Curr Opin Biotechnol. 2002 Dec;13(6):621-4. Review.

PMID:
12482524
6.

Synthesis and antiviral activity of new anti-HIV amprenavir bioisosteres.

Rocheblave L, Bihel F, De Michelis C, Priem G, Courcambeck J, Bonnet B, Chermann JC, Kraus JL.

J Med Chem. 2002 Jul 18;45(15):3321-4.

PMID:
12109915
7.

A brief reflection on the development of human retrovirology: the past, the present and the future.

Chermann JC.

J Hum Virol. 2001 Nov-Dec;4(6):289-95. Review. No abstract available.

PMID:
12082395
8.

[Research of status of provirus HIV DNA in non-progressor and progressor of HIV-1 infected persons].

Xu X, Chen L, Wang Q, Chermann JC.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2000 Dec;14(4):333-7.

PMID:
11471019
10.

Synthesis and anti-HIV activity of alpha-thiophenoxy-hydroxyethylamide derivatives.

Medou M, Priem G, Rocheblave L, Pepe G, Meyer M, Chermann JC, Kraus JL.

Eur J Med Chem. 1999 Jul-Aug;34(7-8):625-38.

PMID:
11278047
11.

New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.

Vlieghe P, Bihel F, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Chermann JC, Kraus JL.

J Med Chem. 2001 Mar 1;44(5):777-86.

PMID:
11262088
12.

Synthesis and anti-HIV evaluation of new 2',3'-dideoxy-3'-thiacytidine prodrugs.

Mourier N, Camplo M, Della Bruna GS, Pellacini F, Ungheri D, Chermann JC, Kraus JL.

Nucleosides Nucleotides Nucleic Acids. 2000 Jul;19(7):1057-91.

PMID:
10999248
13.

Use of proline bioisosteres in potential HIV protease inhibitors: phenylalanine-2-thiophenoxy-3-pyrrolidinone: synthesis and anti-HIV evaluation.

Kraus JL, Bouygues M, Courcambeck J, Chermann JC.

Bioorg Med Chem Lett. 2000 Sep 4;10(17):2023-6.

PMID:
10987441
14.

New anti-HIV derivatives: synthesis and antiviral evaluation.

De Michelis C, Rocheblave L, Priem G, Chermann JC, Kraus JL.

Bioorg Med Chem. 2000 Jun;8(6):1253-62.

PMID:
10896105
15.
16.

Antiviral and anticoagulant activities of a water-soluble fraction of the marine diatom Haslea ostrearia.

Bergé JP, Bourgougnon N, Alban S, Pojer F, Billaudel S, Chermann JC, Robert JM, Franz G.

Planta Med. 1999 Oct;65(7):604-9.

PMID:
10575374
17.

New polyazamacrocycle-nucleoside conjugates: synthesis, anti-HIV evaluation and interaction with CXCR-4 coreceptor.

Dessolin J, Galéa P, Vlieghe P, Chermann JC, Kraus JL.

Nucleosides Nucleotides. 1999 Apr-May;18(4-5):881-2.

PMID:
10432701
18.

Synthesis and biological evaluation of polyaminated 2',3'-dideoxy-3'-thiacytidine prodrugs.

Camplo M, Mourier N, Chermann JC, Kraus JL.

Nucleosides Nucleotides. 1999 Apr-May;18(4-5):879-80.

PMID:
10432700
19.

Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity.

Klein JL, Roberts JD, George MD, Kurtzberg J, Breton P, Chermann JC, Olden K.

Br J Cancer. 1999 Apr;80(1-2):87-95.

20.

HIV as the cause of AIDS and associated diseases.

Galéa P, Chermann JC.

Genetica. 1998;104(2):133-42. Review.

PMID:
10220906
21.
22.

Role of Kaposi's sarcoma cells in recruitment of circulating leukocytes: implications in pathogenesis.

Galea P, Frances V, Dou-Dameche L, Sampol J, Chermann JC.

J Hum Virol. 1998 May-Jun;1(4):273-81.

PMID:
10195252
23.
24.

Rationale for a vaccine using cellular-derived epitope presented by HIV isolates.

Galéa P, le Contel C, Coutton C, Chermann JC.

Vaccine. 1999 Mar 26;17(13-14):1700-5. Review.

PMID:
10194825
25.

New bicyclam-AZT conjugates: design, synthesis, anti-HIV evaluation, and their interaction with CXCR-4 coreceptor.

Dessolin J, Galea P, Vlieghe P, Chermann JC, Kraus JL.

J Med Chem. 1999 Jan 28;42(2):229-41.

PMID:
9925728
26.

Design, synthesis and structure relationships of new N,N',N",N"'-tetrakis (omega-amino alkyl) tetraazamacrocycles.

Trabaud C, Dessolin J, Camplo M, Hantz O, Zoulim F, Borel C, Meyer M, Pepe G, Chermann JC, Kraus JL.

Antivir Chem Chemother. 1998 Jan;9(1):73-84.

PMID:
9875379
27.

Synthesis and anti-HIV activities of symmetrical N1,N3-dibenzyl-2-hydroxy-propane derivatives.

Medou M, Bouygues M, Rocheblave L, Chermann JC, Kraus JL.

Bioorg Med Chem Lett. 1998 Jul 21;8(14):1861-6.

PMID:
9873448
28.

Syntheses of new modified Phe-Pro peptides. Use of proline replacements in potential HIV inhibitors.

Bouygues M, Medou M, Quéléver G, Chermann JC, Camplo M, Kraus JL.

Bioorg Med Chem Lett. 1998 Feb 3;8(3):277-80.

PMID:
9871669
29.

Primary intestinal epithelial cells can be infected with laboratory-adapted strain HIV type 1 NDK but not with clinical primary isolates.

Chenine AL, Matouskova E, Sanchez G, Reischig J, Pavlikova L, LeContel C, Chermann JC, Hirsch I.

AIDS Res Hum Retroviruses. 1998 Sep 20;14(14):1235-8.

PMID:
9764906
30.

Sexual and mother-to-child transmission of the human immunodeficiency virus type 1: a review.

Chermann JC.

Am J Reprod Immunol. 1998 Sep;40(3):183-6. Review.

PMID:
9764363
31.

Tri-N-Boc-tetraazamacrocycle-nucleoside conjugates: synthesis and anti-HIV activities.

Dessolin J, Vlieghe P, Bouygues M, Medou M, Quéléver G, Camplo M, Chermann JC, Kraus JL.

Nucleosides Nucleotides. 1998 May;17(5):957-68.

PMID:
9708333
32.

Neutralizing antibodies in Brazilian sera against three strains of human immunodeficiency virus type 1 (HIV-1).

Machado AA, Hirsch I, Figueiredo JF, Martinez R, Chermann JC.

Rev Inst Med Trop Sao Paulo. 1997 Nov-Dec;39(6):319-22.

PMID:
9674281
33.

Apoptosis of CD4+ T cells induced after contact with HIV1-infected or non-infected macrophages.

Godard CM, Serriès H, Fulachier C, Chermann JC.

Res Virol. 1997 Nov-Dec;148(6):383-96.

PMID:
9498010
34.

[HIV virus detection in ejaculates collected at different times in seropositive patients].

Bréchard N, Galéa P, Silvy F, Amram M, Chermann JC.

Contracept Fertil Sex. 1997 Sep;25(9):725-9. French.

PMID:
9410396
35.

In vitro study of Seraspenide on HIV-induced inhibition of granulopoiesis.

Coutton C, Chermann JC.

Eur J Haematol. 1997 Sep;59(3):184-9.

PMID:
9310127
36.

[Study of HIV localization in sperm].

Bréchard N, Galéa P, Silvy F, Amram M, Chermann JC.

Contracept Fertil Sex. 1997 May;25(5):389-91. French.

PMID:
9273111
38.

Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression.

Galea P, Vermot-Desroches C, Le Contel C, Wijdenes J, Chermann JC.

Res Immunol. 1997 Feb;148(2):109-17. Review.

PMID:
9226765
39.

[Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1)].

Machado AA, Hirsch I, Figueiredo JF, Martinez R, de Freitas-Silva G, Chermann JC, Covas DT.

Rev Soc Bras Med Trop. 1996 Nov-Dec;29(6):615-7. Portuguese. No abstract available.

PMID:
9011891
40.

Genetic control of infection of primary macrophages with T-cell-tropic strains of HIV-1.

Hirsch I, de Mareuil J, Salaun D, Chermann JC.

Virology. 1996 May 1;219(1):257-61.

41.

Interface peptides as structure-based human immunodeficiency virus reverse transcriptase inhibitors.

Divita G, Baillon JG, Rittinger K, Chermann JC, Goody RS.

J Biol Chem. 1995 Dec 1;270(48):28642-6.

42.

Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV-1 NDK.

De Mareuil J, Salaun D, Chermann JC, Hirsch I.

Virology. 1995 Jun 1;209(2):649-53.

43.

HIV Tat protein potentiates in vitro granulomonocytic progenitor cell growth.

Calenda V, Chermann JC.

Eur J Haematol. 1995 Mar;54(3):180-5.

PMID:
7536687
44.

Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa.

Machado AA, Bakpabua M, Salaun D, de Mareuil J, Krchnak V, MacGregor RR, Chermann JC, Hirsch I.

Vaccine. 1995 Feb;13(3):321-5.

PMID:
7631521
45.

Lectin-mediated effects on HIV type 1 infection in vitro.

Hammar L, Hirsch I, Machado AA, De Mareuil J, Baillon JG, Bolmont C, Chermann JC.

AIDS Res Hum Retroviruses. 1995 Jan;11(1):87-95.

PMID:
7734200
46.

Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates.

Charvet AS, Turin F, Faury P, Hantz O, Camplo M, Mourier N, Berthillon P, Graciet JC, Chermann JC, Trépo C, et al.

Antiviral Res. 1994 Oct;25(2):161-8.

PMID:
7847877
47.

Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates.

Charvet AS, Camplo M, Faury P, Graciet JC, Mourier N, Chermann JC, Kraus JL.

J Med Chem. 1994 Jul 8;37(14):2216-23.

PMID:
8035429
48.

Lectin effects on HIV-1 infectivity.

Hammar L, Hirsch I, Machado A, De Mareuil J, Baillon J, Chermann JC.

Ann N Y Acad Sci. 1994 Jun 6;724:166-9.

PMID:
8030938
49.
50.

Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells.

Calenda V, Graber P, Delamarter JF, Chermann JC.

Eur J Haematol. 1994 Feb;52(2):103-7.

PMID:
8119379

Supplemental Content

Loading ...
Support Center